Literature DB >> 24652966

RAS-associated lymphoproliferative disease evolves into severe juvenile myelo-monocytic leukemia.

Nina Lanzarotti1, Julie Bruneau, Amélie Trinquand, Marie-Claude Stolzenberg, Bénédicte Neven, Julien Fregeac, Eva Levy, Nadia Jeremiah, Felipe Suarez, Nizar Mahlaoui, Alain Fischer, Aude Magerus-Chatinet, Hélène Cavé, Frédéric Rieux-Laucat.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24652966     DOI: 10.1182/blood-2014-01-548958

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Somatic mosaicism for a NRAS mutation associates with disparate clinical features in RAS-associated leukoproliferative disease: a report of two cases.

Authors:  Mitsutaka Shiota; Xi Yang; Mei Kubokawa; Tatsuya Morishima; Kuniaki Tanaka; Masamitsu Mikami; Kenichi Yoshida; Masako Kikuchi; Kazushi Izawa; Ryuta Nishikomori; Yusuke Okuno; Xian Wang; Hirotoshi Sakaguchi; Hideki Muramatsu; Seiji Kojima; Satoru Miyano; Seishi Ogawa; Masatoshi Takagi; Daisuke Hata; Hirokazu Kanegane
Journal:  J Clin Immunol       Date:  2015-04-21       Impact factor: 8.317

Review 2.  RAS diseases in children.

Authors:  Charlotte M Niemeyer
Journal:  Haematologica       Date:  2014-11       Impact factor: 9.941

Review 3.  JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities.

Authors:  Katherine R Calvo; Susan Price; Raul C Braylan; Joao Bosco Oliveira; Michael Lenardo; Thomas A Fleisher; V Koneti Rao
Journal:  Blood       Date:  2015-02-17       Impact factor: 22.113

Review 4.  Pediatric Neoplasms Presenting with Monocytosis.

Authors:  Jacob R Greenmyer; Mira Kohorst
Journal:  Curr Hematol Malig Rep       Date:  2021-02-25       Impact factor: 3.952

Review 5.  Turning the tide in myelodysplastic/myeloproliferative neoplasms.

Authors:  Michael W N Deininger; Jeffrey W Tyner; Eric Solary
Journal:  Nat Rev Cancer       Date:  2017-06-23       Impact factor: 60.716

6.  Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5.

Authors:  Dita Gratzinger; Elaine S Jaffe; Amy Chadburn; John K C Chan; Daphne de Jong; John R Goodlad; Jonathan Said; Yasodha Natkunam
Journal:  Am J Clin Pathol       Date:  2017-02-01       Impact factor: 2.493

7.  RAS-associated Autoimmune Leukoproliferative disease (RALD) manifested with early-onset SLE-like syndrome: a case series of RALD in Chinese children.

Authors:  Wei Wang; Yu Zhou; Linqing Zhong; Lin Wang; Xiaoyan Tang; Mingsheng Ma; Ji Li; Hongmei Song
Journal:  Pediatr Rheumatol Online J       Date:  2019-08-14       Impact factor: 3.054

8.  Juvenile myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment.

Authors:  Astrid Wintering; Christopher C Dvorak; Elliot Stieglitz; Mignon L Loh
Journal:  Blood Adv       Date:  2021-11-23

Review 9.  ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.

Authors:  Filippo Consonni; Eleonora Gambineri; Claudio Favre
Journal:  Ann Hematol       Date:  2022-01-20       Impact factor: 3.673

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.